API

Event: 89

Key Event Title

?

Synthesis, De Novo FA

Short name

?

Synthesis, De Novo FA

Biological Context

?

Level of Biological Organization
Cellular

Cell term

?

Cell term
hepatocyte


Organ term

?


Key Event Components

?

Process Object Action
fatty acid biosynthetic process fatty acid increased

Key Event Overview


AOPs Including This Key Event

?

AOP Name Role of event in AOP
LXR Activation to Liver Steatosis KeyEvent

Stressors

?


Taxonomic Applicability

?


Life Stages

?


Sex Applicability

?


Key Event Description

?


A number of pathways and a great number of enzymes like GK, L-PK, ACC, FAS and SCD-1 are involved in the de novo FA synthesis [1]. As it is already discussed above these enzymes are induced by LXR agonists (FAS, SCD1), the SREBP-1c (GK, ACC, FAS) and the ChREBP (L-PK, ACC, FAS) leading to enhancement of the de novo FA synthesis.


Metabolic-pathway-for-de-novo-FA-synthesis-and-TG-formation.png


Figure 1. Metabolic pathway for de novo FA synthesis and TG formation [1]

As proposed from Diraison et al 1997 the de novo FA synthesis contributes maximum 5% to the synthesis of FA and TG under normal conditions. Conditions associated with high rates of lipogenesis, such as low fat - high carbohydrate (LF/HC) diet, hyperglycemia, and hyperinsulinemia are associated with a shift in cellular metabolism from lipid oxidation to TG esterification, thereby increasing the availability of TGs derived from VLDL synthesis and secretion.


How It Is Measured or Detected

?



Domain of Applicability

?



References

?


  1. 1.0 1.1 Postic & Girard 2008